New concepts in the pathophysiology of infective endocarditis

Current Infectious Disease Reports

Volumn 8, Issue 4, 2006, Pages 271-279

  Widmer, Eleonora ^b   Que, Yok Ai ^b   Entenza, José M ^b   Moreillon, Philippe ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRONECTIN; IMMUNOMODULATING AGENT; INTEGRIN; THROMBOPLASTIN;

APOPTOSIS; BACTERIAL ENDOCARDITIS; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CHEMOTAXIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIUM; ENDOTHELIUM LESION; HEART VALVE; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; MICROBIAL COLONIZATION; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; THROMBOCYTE;

EID: 33746053241     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0071-z     Document Type: Review

References (50)

1. Moreillon P, Que YA: Infective endocarditis. Lancet 2004, 363:139-149.
2. Bouza E, Menasalvas A, Munoz P, et al.: Infective endocarditis - a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 2001, 80:298-307.
3. Abbott KC, Agodoa LY: Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron 2002, 91:203-209.
4. Croft LB, Donnino R, Shapiro R, et al.: Age-related prevalence of cardiac valvular abnormalities warranting infectious endocarditis prophylaxis. Am J Cardiol 2004, 94:386-389.
5. Camerer E, Kolsto AB, Prydz H: Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996,81:1-41.
6. Yeaman MR: The role of platelets in antimicrobial host defense. Clin Infect Dis 1997, 25:951-968.
7. Veltrop MH, Beekhuizen H, Thompson J: Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells. Infect Immun 1999, 67:6130-6138.
8. Bancsi MJ, Veltrop MH, Bertina RM, et al.: Role of monocytes and bacteria in Staphylococcus epidermidis endocarditis. Infect Immun 1998, 66:448-450.
9. Bancsi MJ, Thompson J, Bertina RM: Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun 1994, 62:5669-5672.
10. Veltrop MH, Thompson J, Beekhuizen H: Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells. Infect Immun 2001, 69:2797-2807.
11. Dankert J, van der Werff J, Joldersma W, et al.: Interleukin 1alpha increases the susceptibility of rabbits to experimental viridans streptococcal endocarditis. Infect Immun 2006, 74:947-952.
12. Erickson PR, Herzberg MC: The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain. J Biol Chem 1993, 268:1646-1649.
13. Manning JE, Hume EB, Hunter N, et al.: An appraisal of the virulence factors associated with streptococcal endocarditis. J Med Microbiol 1994, 40:110-114.
14. Moreillon P, Que YA, Bayer AS: Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am 2002, 16:297-318.
15. Bensing BA, Siboo IR, Sullam PM: Proteins PblA and PblB of Streptococcus mitis, which promote binding to human platelets, are encoded within a lysogenic bacteriophage. Infect Immun 2001, 69:6186-6192.
16. Fitzgerald JR, Loughman A, Keane F, et al.: Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol 2006, 59:212-230.
17. Loughman A, Fitzgerald JR, Brennan MP, et al.: Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 2005, 57:804-818.
18. Siboo IR, Chambers HF, Sullam PM: Role of SraP, a serine-rich surface protein of Staphylococcus aureus, in binding to human platelets. Infect Immun 2005, 73:2273-2280.
19. Bayer AS, Sullam PM, Ramos M, et al.: Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun 1995, 63:3634-3641.
20. Sullam PM, Bayer AS, Foss WM, et al.: Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun 1996, 64:4915-4921.
21. Sullam PM, Frank U, Yeaman MR, et al.: Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis 1993, 168:910-914.
22. Dankert J, Van den Werff J, Zaat SAJ, et al.: Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 1995, 63:663-671.
23. Koo SP, Bayer AS, Kagan BL, et al.: Membrane permeabilization by thrombin-induced platelet microbicidal protein 1 is modulated by transmembrane voltage polarity and magnitude. Infect Immun 1999, 67:2475-2481.
24. Weidenmaier C, Peschel A, Kempf VA, et al.: DItABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect Immun 2005, 73:8033-8038.
25. Fowler VG Jr, McIntyre LM, Yeaman MR, et al.: In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 2000, 182:1251-1254.
26. Taha TH, Durrant SS, Mazeika PK, et al.: Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis. J Intern Med 1992, 231:543-546.
27. Nicolau DP, Tessier PR, Nightingale CH: Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 1999, 11:159-161.
28. Kupferwasser LI, Yeaman MR, Nast CC, et al.: Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003, 112:222-233.
29. Tornos P, Almirante B, Mirabet S, et al.: Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 1999, 159:473-475.
30. Mc Entergart MG, Porterfield JS: Bacteremia following dental extraction. Lancet 1949, 2:596-598.
31. Hall C, Heimdahl A, Nord CE: Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis. Clin Infect Dis 1999, 29:1-8; quiz 9-10.
32. Bahn SL, Goveia G, Bitterman P, et al.: Experimental endocarditis induced by dental manipulation and oral streptococci. Oral Surg Oral Med Oral Pathol 1978, 45:549-559.
33. Patti JM, Allen BL, McGavin MJ, et al.: MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994, 48:585-617.
34. Shun CT, Lu SY, Yeh CY, et al.: Glucosyltransferases of viridans streptococci are modulins of interleukin-6 induction in infective endocarditis. Infect Immun 2005, 73:3261-3270.
35. Viscount HB, Munro CL, Burnette-Curley D, et al.: Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect Immun 1997, 65:994-1002.
36. Navarre WW, Schneewind O: Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 1999, 63:174-229.
37. Palma M, Haggar A, Flock JI: Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol 1999, 181:2840-2845.
38. Heilmann C, Hartleib J, Hussain MS, et al.: The multifunctional Staphylococcus aureus autolysin aaa mediates adherence to immobilized fibrinogen and fibronectin. Infect Immun 2005, 73:4793-4802.
39. Weidenmaier C, Peschel A, Xiong YQ, et al.: Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 2005, 191:1771-1777.
40. Que YA, Haefliger JA, Piroth L, et al.: Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005, 201:1627-1635.
41. Roche FM, Downer R, Keane F, et al.: The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin. J Biol Chem 2004, 279:38433-38440.
42. Massey RC, Kantzanou MN, Fowler T, et al.: Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell Microbiol 2001, 3:839-851.
43. Wann E, Gurusiddappa S, Höök M: The fibronectin-binding MSRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem 2000, 275:13863-13871.
44. Roche FM, Massey R, Peacock SJ, et al.: Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. Microbiology 2003, 149(Pt 3):643-654.
45. Massey R, Dissanayeke S, Cameron B, et al.: Functional blocking of Staphylococcus aureus adhesins following growth in ex vivo media. Infect Immun 2002,70:5339-5345.
46. Cheung AL, Projan SJ, Gresham H: The genomic aspect of virulence, sepsis, and resistance to killing mechanisms in Staphylococcus aureus. Curr Infect Dis Rep 2002, 4:400-410.
47. Cheung AL, Eberhardt KJ, Chung E, et al.: Diminished virulence of a sar-/ agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 1994, 94:1815-1822.
48. Mayville P, Ji G, Beavis R, et al.: Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci U S A 1999, 96:1218-1223.
49. Entenza JM, Moreillon P, Senn MM, et al.: Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infect Immun 2005, 73:990-998.
50. Bayer AS, Ramos MD, Menzies BE, et al.: Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun 1997, 65:4652-4660.